41 pending office actions • 12 clients • 41 examiners • 32 art units • 0 of 41 (0%) have an AI response strategy ready • 34 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 18 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 18 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 25 (61%) |
| §102 only | 8 (20%) |
| §112 only | 3 (7%) |
| Double-patenting only | 3 (7%) |
| No statute on record | 2 (5%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POPESCU, GABRIEL VICTOR | 1 | 63.3% | +30.5% |
| SCHLEIS, DANIEL J | 1 | 71.5% | +5.2% |
| JACKSON, SHAWQUIA | 1 | 78.0% | -3.4% |
| ROSENTHAL, ANDREW S | 1 | 51.4% | +40.6% |
| ARMSTRONG, SUSANNAH SIPPLE | 1 | 32.0% | +46.7% |
| CORNET, JEAN P | 1 | 42.0% | +47.6% |
| SHOWALTER, ALEXANDER KEITH | 1 | 54.9% | +50.7% |
| GALSTER, SAMUEL LEONARD | 1 | 53.2% | +40.6% |
| KINSEY WHITE, NICOLE ERIN | 1 | 57.9% | +16.3% |
| TOWNSLEY, SARA ELIZABETH | 1 | 25.1% | +48.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18512950 | Small Molecule Degraders of DOT1L and Uses Thereof | TOWNSLEY, SARA ELIZABETH | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19215178 | INFRARED THERMOGRAPHY FOR INTRAOPERATIVE FUNCTIONAL MAPPING | POPESCU, GABRIEL VICTOR | — |
| 18694853 | NANOPARTICULATE MONOBENZONE FOR TREATING MELANOMA | ROSENTHAL, ANDREW S | — |
| 18691863 | LIPIODOL FORMULATION FOR TRANSARTERIAL CHEMOIMMUNOEMBOLIZATION | ARMSTRONG, SUSANNAH SIPPLE | — |
| 18434367 | MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS | CORNET, JEAN P | — |
| 18006688 | CLOTRIMAZOLE AS A TREATMENT FOR IMMUNODEFICIENCY DISORDERS | SHOWALTER, ALEXANDER KEITH | — |
| 18391200 | METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS CLASS I MUTATIONS | GALSTER, SAMUEL LEONARD | — |
| 18515196 | TGF-BETA INHIBITION FOR IMMUNODEFICIENCY VIRUS REACTIVATION FROM LATENCY, ENHANCEMENT OF IMMUNODEFICIENCY VIRUS-SPECIFIC RESPONSES AND IMMUNODEFICIENCY VIRUS CURE | KINSEY WHITE, NICOLE ERIN | — |
| 18512950 | Small Molecule Degraders of DOT1L and Uses Thereof | TOWNSLEY, SARA ELIZABETH | — |
| Art Unit | Apps |
|---|---|
| 1629 | 3 |
| 1693 | 3 |
| 1691 | 2 |
| 1682 | 2 |
| 1671 | 2 |
| 1647 | 2 |
| 3797 | 1 |
| 1784 | 1 |
| 1613 | 1 |
| 1616 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19215178 | INFRARED THERMOGRAPHY FOR INTRAOPERATIVE FUNCTIONAL MAPPING | Northwestern University | POPESCU, GABRIEL VICTOR | 3797 | — | Non-Final OA | — | Pending | May 21, 2025 |
| 18880219 | REACTIVE OXYGEN SPECIES RESPONSIVE CLEAVABLE HIERARCHIAL METALLIC SUPRANANOSTRUCTURES | Northwestern University | SCHLEIS, DANIEL J | 1784 | §102 | Non-Final OA | — | Pending | Dec 30, 2024 |
| 18821660 | USE OF NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS FOR IMMUNOTHERAPY IN MELANOMA PATIENTS | Chapman University | JACKSON, SHAWQUIA | DP | Non-Final OA | — | Pending | Aug 30, 2024 | |
| 18694853 | NANOPARTICULATE MONOBENZONE FOR TREATING MELANOMA | Northwestern University | ROSENTHAL, ANDREW S | 1613 | §103 | Final Rejection | — | Pending | Mar 22, 2024 |
| 18691863 | LIPIODOL FORMULATION FOR TRANSARTERIAL CHEMOIMMUNOEMBOLIZATION | Northwestern University | ARMSTRONG, SUSANNAH SIPPLE | 1616 | §103 | Non-Final OA | — | Pending | Mar 13, 2024 |
| 18434367 | MODULATION OF SEX STEROID HORMONE PRODUCTION AND ACTIVITY FOR TREATING AND PREVENTING HERNIAS | Northwestern University | CORNET, JEAN P | 1628 | §103 | Non-Final OA | — | Pending | Feb 06, 2024 |
| 18006688 | CLOTRIMAZOLE AS A TREATMENT FOR IMMUNODEFICIENCY DISORDERS | Northwestern University | SHOWALTER, ALEXANDER KEITH | 1629 | §103 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18391200 | METHODS AND COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS CLASS I MUTATIONS | Ann & Robert H. Lurie Children's Hospital of Chicago | GALSTER, SAMUEL LEONARD | 1693 | DP | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18515196 | TGF-BETA INHIBITION FOR IMMUNODEFICIENCY VIRUS REACTIVATION FROM LATENCY, ENHANCEMENT OF IMMUNODEFICIENCY VIRUS-SPECIFIC RESPONSES AND IMMUNODEFICIENCY VIRUS CURE | Northwestern University | KINSEY WHITE, NICOLE ERIN | 1672 | — | Non-Final OA | — | Pending | Nov 20, 2023 |
| 18512950 | Small Molecule Degraders of DOT1L and Uses Thereof | Northwestern University | TOWNSLEY, SARA ELIZABETH | 1629 | §112 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18467698 | NEDDYLATION INHIBITION FOR USE IN THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION | Northwestern University | FOWLER, ALAN JEROME | 1691 | §103 | Non-Final OA | 37d overdue | Pending | Sep 14, 2023 |
| 18466599 | RATIONAL DESIGN, OPTIMIZATION, AND BIOLOGICAL EVALUATION OF NOVEL MEK4 INHIBITORS AGAINST PANCREATIC ADENOCARCINOMA | Northwestern University | CHEN, PO-CHIH | 1621 | §103 | Final Rejection | — | Pending | Sep 13, 2023 |
| 18465749 | HIERARCHICAL NANOPOROUS DIAMONDOID SUPERSTRUCTURE | King Abdulaziz City For Science And Technology | JARRELL, NOBLE E | 1699 | §102 | Non-Final OA | 22d | Pending | Sep 12, 2023 |
| 18548784 | (S)-3-AMINO-4,4-DIHALOCYCLOPENT-1-ENECARBOXYLIC ACID AS SELECTIVE INACTIVATORS OF HUMAN ORNITHINE AMINOTRANSFERASE | Northwestern University | CHICKS, ASHLI ARIANA | 1626 | §103 | Non-Final OA | 13d | Pending | Sep 01, 2023 |
| 18548175 | CELL-FREE BIOSENSORS WITH DNA STRAND DISPLACEMENT CIRCUITS | Northwestern University | SALMON, KATHERINE D | 1682 | DP | Non-Final OA | — | Pending | Aug 28, 2023 |
| 18330874 | INHIBITORS OF THE INTERACTION BETWEEN TRIP8B AND HCN CHANNELS AND USES THEREOF FOR TREATING NEUROLOGICAL DISEASES AND DISORDERS | Northwestern University | SAWYER, JENNIFER C | 1691 | §102 | Non-Final OA | 2d overdue | Pending | Jun 07, 2023 |
| 18328967 | Portable Closed System for Culturing Cells Using Small Volumes of Capillary Blood | Northwestern University | LEPAGE, JONATHAN EVERETT | 1796 | §103 | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18251604 | A CELL-FREE BIO-MANUFACTURING PLATFORM FOR PRODUCTION OF FATTY ACIDS AND CANNABINOIDS | Northwestern University | RAMIREZ, DELIA M | 1652 | §102 | Non-Final OA | — | Pending | May 03, 2023 |
| 18251596 | METHODS FOR FULL-LENGTH REVERSE TRANSCRIPTION PCR OF LONG RNAs CONTAINING MODIFIED RIBONUCLEOSIDES USING A THERMOSTABLE REVERSE TRANSCRIPTASE | Northwestern University | GREENE, CAROLYN LEE | 1681 | §103 | Non-Final OA | — | Pending | May 03, 2023 |
| 18308349 | METHODS FOR IMPROVING COVID VACCINE IMMUNOGENICITY | Northwestern University | TANG, JIANMING | 1671 | §102 | Non-Final OA | 46d overdue | Pending | Apr 27, 2023 |
| 18249057 | USE OF REELIN FOR TREATING CARDIAC DISEASES | Northwestern University | BUTTICE, AUDREY L | 1647 | §103 | Non-Final OA | 16d overdue | Pending | Apr 13, 2023 |
| 18040888 | METHODS OF TREATING MALIGNANT GLIOBLASTOMA | The Trustees of Columbia University in the City of New York | STOICA, ELLY GERALD | 1647 | §103 | Final Rejection | 22d | Pending | Feb 07, 2023 |
| 18005826 | ENGINEERED N-GLYCOSYLTRANSFERASES WITH ALTERED SPECIFICITIES | Northwestern University | EIX, EMILY FAY | 1653 | §103 | Final Rejection | — | Pending | Jan 17, 2023 |
| 18004104 | HUMAN RECOMBINANT ACE2-FC MUTANTS THAT DECOUPLE ANTI-SARS-COV-2 ACTIVITY FROM CARDIOVASCULAR EFFECTS | Northwestern University | NIEBAUER, RONALD T | 1658 | §103 | Final Rejection | — | Pending | Jan 03, 2023 |
| 18003911 | A SINGLE PATIENT CLASSIFIER FOR T1 HIGH GRADE BLADDER CANCER | Dxige Research, Inc. | STUBBS, JOHN THOMAS | 1686 | §103 | Non-Final OA | — | Pending | Dec 29, 2022 |
| 18002940 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF COVID-19 AND ASSOCIATED RESPIRATORY DISTRESS AND MULTI-ORGAN FAILURE, SEPSIS, ACUTE RESPIRATORY DISTRESS SYNDROME, AND CARDIOVASCULAR DISEASES | Ann & Robert H. Lurie Children's Hospital of Chicago | WELLS, LAUREN QUINLAN | 1622 | §103 | Final Rejection | 56d overdue | Pending | Dec 22, 2022 |
| 18002457 | PROCESS FOR DIRECT READOUT OF IMMUNOGLOBULINS | Northwestern University | XU, XIAOYUN | 1797 | §103 | Final Rejection | 28d | Pending | Dec 19, 2022 |
| 18058419 | RNA-DIRECTED DNA CLEAVAGE AND GENE EDITING BY CAS9 ENZYME FROM NEISSERIA MENINGITIDIS | Wisconsin Alumni Research Foundation | GROOMS, TIFFANY NICOLE | 1637 | §103 | Final Rejection | — | Pending | Nov 23, 2022 |
| 17997013 | Small Molecule Inhibitors That Block the Budding of Enveloped Viruses | Northwestern University | MCDOWELL, BRIAN E | 1624 | §103 | Non-Final OA | 15d | Pending | Oct 24, 2022 |
| 18048673 | A SYNTHENTIC POLY-TRANSTHYRETIN AFFINITY TRAP FOR DETECTING AMYLOIDOGENIC TRANSTHYRETIN FORMS IN PLASMA SAMPLES OFTRANTHYRETIN AMYLOIDOSIS PATIENTS | Northwestern University | DUNN, MCKENZIE A | 1678 | §103 | Final Rejection | — | Pending | Oct 21, 2022 |
| 17907374 | MECHANICAL-BOND-PROTECTED STABLE BISRADICALS | Northwestern University | TRAN, ERIC | 1629 | §112 | Non-Final OA | — | Pending | Sep 26, 2022 |
| 17932320 | NON-NEUROINVASIVE VIRUSES AND USES THEREOF | Trustees Of Tufts College (Aka Tufts University) | LI, BAO Q | 1671 | §112 | Non-Final OA | 3d overdue | Pending | Sep 15, 2022 |
| 17904211 | LONG CHAIN CARBON AND CYCLIC AMINO ACIDS SUBSTRATES FOR GENETIC CODE REPROGRAMMING | The Board Of Trustees Of The University Of Illinois | OLSON, ANDREA STEFFEL | 1693 | §103 | Non-Final OA | 43d overdue | Pending | Aug 12, 2022 |
| 17760040 | Polyelectrolyte Single Crystal for Proton Conductivity | King Abdulaziz City For Scince And Technology (Kacst) | ROSWELL, JESSICA MARIE | 1767 | §102 | Final Rejection | — | Pending | Aug 03, 2022 |
| 17757746 | AQUEOUS RECHARGEABLE ZINC BATTERIES | Newsouth Innovations Pty Ltd | CHUO, TONY SHENG HSIANG | 1751 | §103 | Non-Final OA | — | Pending | Jun 20, 2022 |
| 17784891 | METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSE | Northwestern University | REDDIG, PETER J | 1646 | §103 | Non-Final OA | 38d overdue | Pending | Jun 13, 2022 |
| 17838428 | MODULATION OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE LIGASE 1 (UCHL1) EXPRESSION FOR TREATING NEUROLOGICAL DISEASE, DISORDERS, AND INJURIES ASSOCIATED WITH UPPER MOTOR NEURONS | Northwestern University | CORDAS, EMILY ANN | 1632 | §102 | Final Rejection | 13d | Pending | Jun 13, 2022 |
| 17778340 | FLUID MECHANICS-BASED ANALYSIS TOOL TO ESTIMATE FLOW DATA FROM PLANIMETRY CATHETER DATA | Northwestern University | ROBERTS, ANNA L | 3791 | §103 | Non-Final OA | 27d | Pending | May 19, 2022 |
| 17606441 | STABILIZATION AND PRESERVATION OF IN VITRO TRANSCRIPTION REACTIONS | President and Fellows of Harvard College | LEE, HOI YAN NMN | 1693 | §103 | Non-Final OA | 22d overdue | Pending | Oct 25, 2021 |
| 17503057 | ANTI-POLYETHYLENE GLYCOL (PEG) ANTIBODY MOUSE MODEL FOR RIGOROUS ASSESSMENT OF PEG-BASED THERAPIES: ADJUVANT-FREE INDUCTION MODEL | Northwestern University | WEHBE, ANNE MARIE SABRINA | 1634 | §102 | Final Rejection | 14d | Pending | Oct 15, 2021 |
| 17594119 | MARKERS OF EFFICACY OF TOPOISOMERASE POISONS | Northwestern University | KENNEDY, SARAH JANE | 1682 | §103 | Non-Final OA | 25d overdue | Pending | Oct 04, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial